SEC Form D · filed September 23, 2025
Dewpoint Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (35)
Ameet A. Nathwani, M.D · Boston, MAExec · DirectorIsaac A. Klein, M.D., Ph.D · Boston, MAExecSrinivas H. Akkaraju, M.D., Ph.D · Boston, MADirectorRegina A. Barzilay, Ph.D · Boston, MADirectorLori A. Escobedo · Boston, MAExecMark A. Murcko, Ph.D · Boston, MADirectorOlivier H. Brandicourt, M.D · Boston, MADirectorRichard A. Young, Ph.D · Boston, MADirectorAnthony A. Hyman, Ph.D · Boston, MADirectorAmerican Revitalization Company, LLC · Nashville, TNExecAdam Silver · San Francisco, CADirectorPaul Coombs · Waterbury, VTDirectorNeil Devani · San Francisco, CADirectorGregg Noble · Waterbury, VTExecJay Bellows · Waterbury, VTDirectorLindsay Gorrill · Waterbury, VTDirectorBraxten Gorrill · Waterbury, VTExec · DirectorMatthew D. Still · Nashville, TNDirectorGuiseppe A. Ciaramella, Ph,D · Boston, MADirectorAmir H. Nashat, Ph.D · Boston, MADirectorElisabeth A. Leiderman · Boston, MAExecFabio H. Pucci, Ph.D · Boston, MADirectorMatias Gandulfo · Montara, CADirectorShawn B. Grosser · Bethesda, MDDirectorPablo Villalba · Wilmington, DEDirectorAndrew Somers · Princeton, NJExecMelanie B. Domres · Bethesda, MDExec · DirectorMatthew B. Campbell · Toronto, Ontario, CanadaDirectorAkash Patel · Princeton, NJDirectorFirat Yerlikaya · Wilmington, DEExecBarry R. Mandel · Milwaukee, WIDirectorGuiseppe A. Ciaramella, Ph,D · Boston, MADirectorAmir H. Nashat, Ph.D · Boston, MADirectorElisabeth A. Leiderman · Boston, MAExecFabio H. Pucci, Ph.D · Boston, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗